Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The coronary sinus is the largest vein of the heart, located in the posterior atrioventricular groove between the left atrium and left ventricle. It acts as the main collector of venous blood from the myocardium, draining deoxygenated blood into the right atrium. Several cardiac veins, including the great, middle, and small cardiac veins, and the oblique vein of the left atrium, converge to form the coronary sinus[1][2][4]. Its anatomical prominence and variability make it a crucial landmark for cardiac electrophysiology and surgical procedures[3][5]. The coronary sinus is not a molecular or pharmacological target but is essential for venous drainage and as a conduit for interventional access in certain heart procedures. Congenital anomalies of the coronary sinus, such as atresia or diverticulum, may play a role in disease pathogenesis and procedural complications[3].
Not applicable. Drugs do not target the coronary sinus as a molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coronary sinus (CS).